Longitudinal PET imaging of doxorubicin-induced cell death with 18F-annexin v

Molecular Imaging and Biology

Volumn 14, Issue 6, 2012, Pages 762-770

  Hu, Shuo ^a,b   Kiesewetter, Dale O ^b   Zhu, Lei ^b   Guo, Ning ^b   Gao, Haokao ^b   Liu, Gang ^b,c   Hida, Naoki ^b   Lang, Lixin ^b   Niu, Gang ^b   Chen, Xiaoyuan ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

^c AFFILIATED HOSPITAL OF NORTH SICHUAN MEDICAL COLLEGE   (China)

Author keywords

18F Annexin V; Apoptosis; Chemotherapy; Doxorubicin; PET

Indexed keywords

DOXORUBICIN; FLUORINE ANNEXIN V F 18; TRACER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG RESPONSE; DRUG UPTAKE; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TISSUE DISTRIBUTION; TUMOR XENOGRAFT;

ANIMALS; ANNEXIN A5; CELL DEATH; CELL LINE, TUMOR; DOXORUBICIN; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; LIVER; MICE; POSITRON-EMISSION TOMOGRAPHY; STAINING AND LABELING; TISSUE DISTRIBUTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS MUSCULUS;

EID: 84870455411     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-012-0551-5     Document Type: Article

References (35)

1. Young RC, Ozols RF, Myers CE (1981) The anthracycline antineoplastic drugs. N Engl J Med 305:139-153
2. Evan GI, Vousden KH (2001) Proliferation, cell cycle and apoptosis in cancer. Nature 411:342-348
3. Otsuki Y, Li Z, Shibata MA (2003) Apoptotic detection methods -from morphology to gene. Prog Histochem Cytochem 38:275-339
4. Massoud TF, Gambhir SS (2007) Integrating noninvasive molecular imaging into molecular medicine: an evolving paradigm. Trends Mol Med 13:183-191
5. Seddon BM, Workman P (2003) The role of functional and molecular imaging in cancer drug discovery and development. Br J Radiol 76 (Spec No 2):S128-138
6. Niu G, Chen X (2010) Apoptosis imaging: beyond Annexin V. J Nucl Med 51:1659-1662
7. Blankenberg FG, Katsikis PD, Tait JF et al (1998) In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc Natl Acad Sci USA 95:6349-6354
8. Tait JF, CerqueiraMD, Dewhurst TAet al (1994) Evaluation of Annexin V as a platelet-directed thrombus targeting agent. Thromb Res 75:491-501
9. Blankenberg FG, Katsikis PD, Tait JF et al (1999) Imaging of apoptosis (programmed cell death) with 99mTc Annexin V. J Nucl Med 40:184-191
10. Lahorte CM, Vanderheyden JL, Steinmetz N et al (2004) Apoptosisdetecting radioligands: current state of the art and future perspectives. Eur J Nucl Med Mol Imaging 31:887-919
11. Ohtsuki K, Akashi K, Aoka Y et al (1999) Technetium-99m HYNICAnnexin V: a potential radiopharmaceutical for the in-vivo detection of apoptosis. Eur J Nucl Med 26:1251-1258
12. Ke S,Wen X,WuQP et al (2004) Imaging taxane-induced tumor apoptosis using PEGylated, 111In-labeled annexin V. J Nucl Med 45:108-115
13. Haas RL, de Jong D, Valdes Olmos RA et al (2004) In vivo imaging of radiation-induced apoptosis in follicular lymphoma patients. Int J Radiat Oncol Biol Phys 59:782-787
14. Kurihara H, Yang DJ, Cristofanilli M et al (2008) Imaging and dosimetry of 99mTc EC Annexin V: preliminary clinical study targeting apoptosis in breast tumors. Appl Radiat Isot 66:1175-1182
15. Kartachova M, Haas RL, Olmos RA et al (2004) In vivo imaging of apoptosis by 99mTc-annexin V scintigraphy: visual analysis in relation to treatment response. Radiother Oncol 72:333-339
16. Belhocine T, Steinmetz N, Hustinx R et al (2002) Increased uptake of the apoptosis-imaging agent (99m)Tc recombinant human Annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis. Clin Cancer Res 8:2766-2774
17. Niu G, Cai W, Chen X (2008) Molecular imaging of human epidermal growth factor receptor 2 (HER-2) expression. Front Biosci 13:790-805
18. Glaser M, Collingridge DR, Aboagye EO et al (2003) Iodine-124 labelled Annexin-V as a potential radiotracer to study apoptosis using positron emission tomography. Appl Radiat Isot 58:55-62
19. Bauwens M, De Saint-Hubert M, Devos E et al (2011) Site-specific 68Ga-labeled Annexin A5 as a PET imaging agent for apoptosis. Nucl Med Biol 38:381-392
20. Murakami Y, Takamatsu H, Taki J et al (2004) 18F-labelled Annexin V: a PET tracer for apoptosis imaging. Eur J Nucl Med Mol Imaging 31:469-474
21. Yagle KJ, Eary JF, Tait JF et al (2005) Evaluation of 18F-Annexin V as a PET imaging agent in an animal model of apoptosis. J Nucl Med 46:658-666
22. Zhang F, Zhu L, Liu G et al (2011) Multimodality imaging of tumor response to Doxil. Theranostics 1:302-309
23. Carey TE, Van Dyke DL, Worsham MJ et al (1989) Characterization of human laryngeal primary and metastatic squamous cell carcinoma cell lines UM-SCC-17A and UM-SCC-17B. Cancer Res 49:6098-6107
24. Logue SE, Elgendy M, Martin SJ (2009) Expression, purification and use of recombinant Annexin V for the detection of apoptotic cells. Nat Protoc 4:1383-1395
25. Jacobson O, Weiss ID, Kiesewetter DO et al (2010) PET of tumor CXCR4 expression with 4-18F-T140. J Nucl Med 51:1796-1804
26. Beer AJ, Kessler H, Wester HJ et al (2011) PET imaging of integrin alphavbeta3 expression. Theranostics 1:48-57
27. De Saint-Hubert M, Mottaghy FM, Vunckx K et al (2010) Site-specific labeling of 'second generation' Annexin V with 99mTc(CO)3 for improved imaging of apoptosis in vivo. Bioorg Med Chem 18:1356-1363
28. Sun X, Yan Y, Liu S et al (2010) 18F-FPPRGD2 and 18F-FDG PET of response to abraxane therapy. J Nucl Med 52:140-146
29. Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205-216
30. Green AM, Steinmetz ND (2002) Monitoring apoptosis in real time. Cancer J 8:82-92
31. Grierson JR, Yagle KJ, Eary JF et al (2004) Production of [F-18] fluoroannexin for imaging apoptosis with PET. Bioconjug Chem 15:373-379
32. Blankenberg F (2002) To scan or not to scan, it is a question of timing: technetium-99m-annexin V radionuclide imaging assessment of treatment efficacy after one course of chemotherapy. Clin Cancer Res 8:2757-2758
33. Niu G, Li Z, Xie J et al (2009) PET of EGFR antibody distribution in head and neck squamous cell carcinoma models. J Nucl Med 50:1116-1123
34. Niu G, Sun X, Cao Q et al (2010) Cetuximab-based immunotherapy and radioimmunotherapy of head and neck squamous cell carcinoma. Clin Cancer Res 16:2095-2105
35. Blankenberg FG, Naumovski L, Tait JF et al (2001) Imaging cyclophosphamide-induced intramedullary apoptosis in rats using 99mTc-radiolabeled Annexin V. J Nucl Med 42:309-316